Table 1

Demographic and clinical characteristics of participants

Group; no. or mean ± SD
CharacteristicSchizophrenia (n = 27)Control (n = 21)Statistical comparisonp value
Sex, male:female23:417:4χ2 = 0.151p = 0.70
Age, yr29.7 ± 8.629.2 ± 7.9t = −0.198p = 0.84
Parental socioeconomic status*45.8 ± 15.541.6 ± 14.9t = −0.922p = 0.36
IQ99.9 ± 15.2109.3 ± 15.4t = 2.121p = 0.039
Schizophrenia:schizoaffective disorder18:9
Illness duration, yr7.6 ± 7.9
Antipsychotic medication, atypical:typical:atypical + typical24:0:3
Chlorpromazine equivalent, mg547.7 ± 474.7
PANSS
 Positive13.8 ± 6.5
 Negative16.0 ± 6.3
 Cognitive/disorganization9.6 ± 3.0
 Depression/anxiety8.5 ± 3.1
 Excitement/hostility6.6 ± 3.0
SOFI§
 Living situation74.3 ± 16.4
 Instrumental activities of daily living68.1 ± 17.5
 Productive activities and role functioning44.1 ± 26.7
 Social functioning59.7 ± 16.4
  • PANSS = Positive and Negative Syndrome Scale; SD = standard deviation; SOFI = Schizophrenia Objective Functioning Instrument.

  • * Assessed using the Hollingshead index.

  • Assessed using the matrix reasoning and the vocabulary subtests of the Wechsler Adult Intelligence Scale – Fourth Edition.

  • Five-factor model by Lehoux and colleagues. (41)

  • § Data available for 26 patients.